Wiederhold, N. P., Najvar, L. K., Olivo, M., Morris, K. N., Patterson, H. P., Catano, G., & Patterson, T. F. (2021). Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis. Antimicrob Agents Chemother.

Wiederhold, Nathan P., Laura K. Najvar, Marcos Olivo, Kelsey N. Morris, Hoja P. Patterson, Gabriel Catano, a Thomas F. Patterson. "Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida Auris and In Vivo Efficacy With Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis." Antimicrob Agents Chemother 2021.

Wiederhold, Nathan P., et al. "Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida Auris and In Vivo Efficacy With Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis." Antimicrob Agents Chemother 2021.